TAE Life Sciences, Ohio State University partner to advance cancer drug development
TAE Life Sciences (TLS) has signed a letter of intent with the Ohio State University Comprehensive Cancer Center – Arthur…
News
Chinese regulator grants priority review for InnoCare’s solid tumour treatment
FDA accepts Novo Nordisk’s NDA submission for weight management therapy
Pliant cuts workforce by 45% following lung trial termination
Q1 earnings pulse check: companies tentative on pharma-specific tariffs
MHRA authorises Bavarian Nordic’s chikungunya virus vaccine
HHS launches $500m universal vaccines initiative
FDA awards RMAT status to 4DMT diabetic macular oedema therapy
